TY - JOUR
T1 - Soft Tissue Dermal Filler-Associated Necrosis and Impending Necrosis
T2 - A Systematic Review of the Literature
AU - Rentfro, Kathryn
AU - Clarey, Dillon
AU - Glenn, Emily J.
AU - Sulewski, Ronald
AU - Wysong, Ashley
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/10/1
Y1 - 2022/10/1
N2 - BACKGROUNDCosmetic soft tissue fillers are a popular minimally invasive procedure. Necrosis is a rare yet devastating complication of soft tissue fillers. To date, the relationship between soft tissue fillers and necrosis has not been fully described.OBJECTIVETo systematically compile published cases of soft tissue fillers resulting in necrosis and collect data regarding the injection, treatment, and outcome.METHODS AND MATERIALSUsing PRISMA protocol, a comprehensive search for soft tissue filler necrosis was performed using no time constraints, resulting in 97 articles encompassing 192 cases of soft tissue filler necrosis containing individual-level data.RESULTSOf the cases analyzed, 66.1% had progressed to necrosis, whereas 33.9% of patients had impending necrosis. Necrosis most commonly resulted from injection of the nasolabial fold (32.4%, n = 88). The filler material most commonly used was hyaluronic acid (71.9%, n = 138). Hyaluronidase was used most frequently as an initial treatment agent (19.1%, n = 88). Forty-three patients (22.4%) with necrosis had a prior minor procedure or surgery.CONCLUSIONThis systematic review is an extensive overview of necrosis as a complication of soft tissue fillers. It serves as a reference tool for any clinician who injects soft tissue fillers and any provider who encounters soft tissue filler necrosis.
AB - BACKGROUNDCosmetic soft tissue fillers are a popular minimally invasive procedure. Necrosis is a rare yet devastating complication of soft tissue fillers. To date, the relationship between soft tissue fillers and necrosis has not been fully described.OBJECTIVETo systematically compile published cases of soft tissue fillers resulting in necrosis and collect data regarding the injection, treatment, and outcome.METHODS AND MATERIALSUsing PRISMA protocol, a comprehensive search for soft tissue filler necrosis was performed using no time constraints, resulting in 97 articles encompassing 192 cases of soft tissue filler necrosis containing individual-level data.RESULTSOf the cases analyzed, 66.1% had progressed to necrosis, whereas 33.9% of patients had impending necrosis. Necrosis most commonly resulted from injection of the nasolabial fold (32.4%, n = 88). The filler material most commonly used was hyaluronic acid (71.9%, n = 138). Hyaluronidase was used most frequently as an initial treatment agent (19.1%, n = 88). Forty-three patients (22.4%) with necrosis had a prior minor procedure or surgery.CONCLUSIONThis systematic review is an extensive overview of necrosis as a complication of soft tissue fillers. It serves as a reference tool for any clinician who injects soft tissue fillers and any provider who encounters soft tissue filler necrosis.
UR - http://www.scopus.com/inward/record.url?scp=85139509262&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139509262&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000003574
DO - 10.1097/DSS.0000000000003574
M3 - Review article
C2 - 36129182
AN - SCOPUS:85139509262
SN - 1076-0512
VL - 48
SP - 1051
EP - 1056
JO - Dermatologic Surgery
JF - Dermatologic Surgery
IS - 10
ER -